Minurin Flas (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Minurin Flas, is a vasopressin analog presented as a sublingual formulation for sublingual use. It treats central diabetes insipidus, nocturnal enuresis, hemophilia A and von Willebrand disease in appropriate patients.

GNH USA supplies Minurin Flas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin Acetate acts on the antidiuretic hormone pathway and is employed for several endocrine and haemostatic conditions. - Central diabetes insipidus: reduces excessive urine output by enhancing water reabsorption. - Nocturnal enuresis: decreases nighttime bedwetting episodes in children and adolescents. - Hemophilia A: raises plasma factor VIII levels to improve clotting. - Von Willebrand disease: increases von Willebrand factor release to support haemostasis.

Desmopressin Acetate is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Nasal irritation: when administered sublingually may cause local discomfort. - Hyponatraemia: low serum sodium, especially with excessive fluid intake. - Flushing: transient warmth and redness. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Seizures: linked to severe hyponatraemia. - Thrombotic events: rare clot formation in predisposed individuals. - Allergic reaction: rash, itching, or swelling. - Hypertension: sudden increase in blood pressure. - Pulmonary oedema: fluid overload in high‑risk patients.

Before prescribing Desmopressin Acetate, clinicians should consider several safety aspects. - Fluid restriction: limit excessive water intake to prevent hyponatraemia. - Electrolyte monitoring: check serum sodium regularly during therapy. - Cardiovascular disease: use cautiously in patients with hypertension or heart failure. - Pregnancy and lactation: assess risk‑benefit as safety data are limited. - Renal impairment: dose adjustment may be required in reduced kidney function. - Store below 25°C: keep in the original pack, protect from moisture.

Desmopressin Acetate may interact with other medicines that affect water balance or coagulation.

Major Interactions (Avoid): - NSAIDs (e.g., ibuprofen, naproxen): increase risk of hyponatraemia. - Carbamazepine: may reduce desmopressin effectiveness. - Antidiuretic hormone antagonists: counteract therapeutic action.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): potentiate water retention. - Anticoagulants (e.g., warfarin): monitor clotting parameters when used for haemostatic indications. - SSRIs and SNRIs: may contribute to hyponatraemia risk.